China News Service, Beijing, September 30 (Li Jingze) Recently, some media reported that China's vaccine pricing is significantly higher than European and American vaccines.
In this regard, Chinese Foreign Ministry spokesperson Wang Wenbin said at a regular press conference on the 30th that this statement has no basis.
At present, vaccines in various countries are in the process of research and development, and there is great uncertainty about how to price the next step.
Wang Wenbin said that in response to the global new crown pneumonia epidemic, China is stepping up the development of vaccines.
The Chinese side has long announced that after China's vaccine research is completed and put into use, it will serve as a global public product and make China's contribution to the realization of the accessibility and affordability of vaccines in developing countries.
"China's commitment is clear, and we will do what we say," Wang Wenbin said. At present, vaccines in various countries are in the process of research and development, and there is great uncertainty about how to price the vaccine next.
"For China, one thing is clear. We will definitely provide vaccines as a global public product to the world at a fair and reasonable price. We will also provide vaccines to developing countries first in a variety of ways, including donations and free assistance. ."(Finish)